Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Licensees/CRADA partners sought for antiprogestins

March 7, 1997

Bayer initiates international diabetes prevention project

March 6, 1997

Allelix reports progress in osteoporosis trial

March 6, 1997

Novel post-Amadori inhibitors identified

March 5, 1997

Novo Nordisk to develop compounds discovered by Indian research foundation

March 5, 1997

GelTex receives U.S. patent for CholestaGel

March 5, 1997

Antidiabetic/hypolipidemic agents from Sumitomo Metal

March 5, 1997

Pfizer develops ACAT inhibitors

March 5, 1997

First launch for troglitazone

March 4, 1997

Pramlintide delays gastric emptying in IDDM

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...